Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

News Releases

  •   Email
  •   Print
  •   Share

  • A major clinical trial led by researchers at Dana-Farber has shown that a novel agent can protect against the most common viral infection patients face after transplantation.

Tags: StemCellTransplant

  • We have heard from numerous patients, faculty, staff, students and supporters in the last week, many with strong feelings. We appreciate their respectful and constructive concern, and recognize that we all are doing what we think is best for the Institute and the mission we share.

  • A single blood test and basic information about a patient’s medical status can indicate which patients with myelodysplasticsyndrome (MDS) are likely to benefit from a stem cell transplant according to new research by scientists at Dana-Farber.

Tags: StemCellTransplant

  • Dana-Farber CEO and Board Chair respond to a petition to relocate an upcoming Dana-Farber fundraiser.

  • A new Dana-Farber study indicates that every patient with colorectal cancer should raise the idea of genetic testing with their physician. Identifying inherited gene mutations linked to colorectal cancer may help both to improve treatments and prevent disease.

Tags: ColonCancer, Genetics

  • A study led by Dana-Farber researchers provides some of the strongest evidence to date that microorganisms living in the large intestine can serve as a link between diet and certain types of colorectal cancer.

Tags: ColonCancer

  • In the largest clinical study to date of genetic abnormalities in pediatric brain tumors, researchers performed clinical testing on more than 200 tumor samples and found that a majority had genetic irregularities that could influence how the disease was diagnosed and/or treated with approved drugs or agents being evaluated in clinical trials.

Tags: ChildhoodCancer, Genomics

  • Patients with metastatic colorectal cancer may be able to lower the risk of the disease worsening, and improve their chances of survival, if they engage in moderate daily exercise, according to new research by investigators at Dana-Farber.

Tags: ColonCancer, Exercise

  • UMass Memorial Medical Center and Dana-Farber Cancer Institute have notified the Massachusetts Health Policy Commission that UMass Memorial Medical Center intends to become the first academic medical center to join the Dana-Farber Cancer Care Collaborative.

Tags: Partnerships

  • Kenneth C. Anderson, MD, director of the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber, will serve as president of the American Society of Hematology for a year-long term through December 2017.

Tags: Appointments

Showing 1-10 of 753 items